// you’re reading...

Diabetes News

Amylin Seeks FDA Approval on Extended Byetta Treatment – Wall Street Journal


WTHI

Amylin Seeks FDA Approval on Extended Byetta Treatment
Wall Street Journal – David Benoit
The company submitted exenatide, an injection treatment fortype 2 diabetes, after it showed in late March it had the ability to control blood sugar better than current tablet forms ofdiabetesdrugs. The treatment, which is co-developed with Eli Lilly
Exenatide Once Weekly New Drug Application Submitted to FDA forPR Newswire (press release)
Lilly, Amylin, Alkermes file for FDA drug approvalMarketWatch
Amylin, Lilly Seek FDA Approval For First-Ever Once-WeeklyTrading Markets (press release)
San Diego Business Journal –MSN Money
all 199 news articles

Discussion

Comments are disallowed for this post.

Comments are closed.

Tag Cloud

DIABETES Diabetes Symptoms Diabetes Treatment DIET EXERCISE GESTATIONAL Gestational Diabetes glucose tolerance test Juvenile Diabetes TYPE 2

Most Emailed